20.03.2024
^Ad hoc announcement pursuant to Art. 53 LR
* TRYVIO(TM) (aprocitentan) is indicated for the treatment of hypertension in
combination with other antihypertensive drugs, to lower blood pressure in
adult patients who are not adequately controlled...